The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib

The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib was developed by the experts of the Russian Association of Endocrinologists and the Russian Society of Clinical Oncology. The consensus contains recommendation o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalya V. Mazurina, Elena V. Artamonova, Maria F. Beloyartseva, Ekaterina I. Volkova, Inna P. Ganshina, Ekaterina A. Troshina, Sergey A. Tjulandin, Viacheslav A. Chubenko
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2021
Materias:
Acceso en línea:https://doaj.org/article/95b6d9b471d74d51ad5bf1e4d91f076f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!